The role of lymphadenectomy in prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 198-202

  Burkhard, Fiona C ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; NANOPARTICLE;

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FOLLOW UP; HUMAN; ILIAC VEIN; INTERNAL ILIAC ARTERY; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOCELE; LYMPHOSCINTIGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; SENTINEL LYMPH NODE; STATISTICAL SIGNIFICANCE; VEIN THROMBOSIS;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 3242691578     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.032     Document Type: Conference Paper

References (35)

1. Mathiesen O., Carl J., Bonderup O., et al. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol. 29:1990;721-725
2. Siewert J.R., Böttcher K., Stein H.J., et al. Relevant prognostic factors in gastric cancer. Ann Surg. 228:1998;449-461
3. Friedberg V. Results of 108 exenteration operations in advanced gynecologic cancers. Geburtshilfe Frauenheilkd. 49:1989;423-427
4. Caplin S., Cerottini J.P., Bosman F.T., et al. For patients with Duke's B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;666-672
5. Mills R.D., Turner W.H., Fleischmann A., et al. Pelvic lymph node metastases from bladder cancer outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol. 166:2001;19-23
6. Leissner J., Hohenfellner R., Thüroff J.W., et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Br J Urol. 85:2000;817-823
7. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 58:2001;843-848
8. Wolf J.S. Jr, Cher M., Dall'era M., et al. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol. 153:1995;993-999
9. Paik M.L., Scolieri M.J., Brown S.L., et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol. 163:2000;1693-1696
10. Tempany C.M., McNeil B.J. Advances in biomedical imaging. JAMA. 285:2001;562-567
11. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int. 70:2003;303-310
12. Bader P., Burkhard F.C., Markwalder R., et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol. 168:2002;514-518. discussion 518
13. Weingaertner K., Ramaswamy A., Bittinger A., et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer results of an autopsy study and implications for the clinic. J Urol. 156:1996;1969-1971
14. Heidenreich A., Varga Z., Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy high incidence of lymph node metastasis. J Urol. 167:2002;1681-1686
15. Bluestein D.L., Bostwick D.G., Bergstralh E.J., et al. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol. 151:1994;1315-1320
16. Petros J.A., Catalona W.J. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol. 147:1992;1574-1575
17. Bishoff J.T., Reyes A., Thompson I.M., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate development of a system of patient selection. Urology. 45:1995;270-274
18. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 348:2003;2491-2499
19. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol. 169:2003;145-147. discussion 147-8
20. Link R.E., Morton R.A. Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am. 28:2001;491-498
21. Burkhard F., Bader P., Schneider E., et al. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol. 42:2002;84
22. Jhaveri F.M., Zippe C.D., Klein E.A., et al. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer 10-year results. Urology. 54:1999;884-890
23. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 28:2001;555-565
24. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol. 169:2003;849-854
25. Catalona W.J., Miller D.R., Kavoussi L.R. Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol. 140:1988;540-543
26. Steinberg G.D., Epstein J.I., Piantadosi S., et al. Management of stage D1 adenocarcinoma of the prostate the Johns Hopkins experience 1974 to 1987. J Urol. 144:1990;1425-1432
27. Sgrignoli A.R., Walsh P.C., Steinberg G.D., et al. Prognostic factors in men with stage D1 prostate cancer identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol. 152:1994;1077-1081
28. deKernion J.B., Neuwirth H., Stein A., et al. Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J Urol. 144:1990;700-703
29. Frazier H.A. 2nd, Robertson J.E., Paulson D.F. Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol. 12:1994;308-312
30. Cadeddu J.A., Partin A.W., Epstein J.I., et al. Stage D1 (T1-3, N1-3, M0) prostate cancer a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 50:1997;251-255
31. Messing E., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer results at 10 years of EST 3886. J Urol. 169:2003;396
32. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597
33. Golimbu M., Morales P., Al-Askari S., et al. Extended pelvic lymphadenectomy for prostatic cancer. J Urol. 121:1979;617-620
34. Holmberg L., Bill-Axelson A., Helgesen F., et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 347:2002;781-789
35. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 167:2002;528-534